Prostate Cancer and You is a monthly podcast presented by the Massachusetts Prostate Cancer Coalition that explores all aspects of the disease.
Subscribe:.rss.atom.json.md.m3u.pls
Live Last read · last published · next check
Saves to your Listen queue, to pick up on another day or another device.
In this special episode recorded live at the Massachusetts Prostate Cancer Coalition Symposium, host Jordan Rich welcomes Dr. Howard Soule, Chief Science Officer Emeritus of the Prostate Cancer Foundation, and Dr. Adam Feldman, Director of Urologic Research at Massachusetts General Hospital, for a wide-ranging conversation about the future of prostate cancer research. Howard Soule, PhD, Chief…
In this special episode recorded live at the Massachusetts Prostate Cancer Coalition Symposium, host Jordan Rich welcomes internationally recognized radiation oncologist Dr. Anthony Zietman for a fascinating discussion on how decades of research have transformed prostate cancer diagnosis and treatment. Dr. Anthony Zietman, Shipley Professor of Radiation Oncology, Emeritus, Massachusetts General…
In this episode of Prostate Cancer and You , host Jordan Rich speaks with Dr. Todd Cohen of Blue Earth Diagnostics about the growing role of radioligand therapy in prostate cancer treatment. Dr. Cohen explains how PSMA-targeted imaging and radioligand therapy work together to identify and treat prostate cancer with greater precision. The discussion covers which patients may be candidates for these…
Today’s “Prostate Cancer and You” podcast features Joshua Kraft, head of Kraft Family Philanthropies and former CEO of Boys & Girls Clubs of Boston. In this conversation with host Jordan Rich, Kraft discusses his experience with prostate cancer, sharing his journey from a PSA test to a Gleason score of 7. Kraft emphasizes the importance of early detection and treatment, as well as the significance…
Today’s “Prostate Cancer and You” podcast features Dr. Adam Kibel is chair of the department of urology at Mass General Brigham. In this conversation with host Jordan Rich, Dr. Kibel discusses a clinical trial focused on using genetic data and MRI to improve early detection of prostate cancer. The trial, involving men aged 40-69, aims to identify high-risk individuals through genetic testing and…
In this second of a two-part podcast episode, Dr. Todd Cohen discusses the role of PSMA PET imaging in prostate cancer active surveillance, highlighting its potential to replace invasive biopsies. Cohen emphasizes the importance of communication and family involvement in active surveillance protocols. Advanced imaging technologies are evolving, offering hope for less invasive and more effective…
In this first of a two-part podcast episode of “Prostate Cancer and You,” brought to you in part by Blue Earth Diagnostics, Dr. Todd Cohen, Blue Earth Diagnostics vice-president of medical affairs, discusses the practice of active surveillance in prostate cancer screening. Cohen explains the advancements in imaging, particularly PSMA PET scans, which have revolutionized prostate cancer detection.…
Today’s “Prostate Cancer and You” podcast features Dr. Jean Joseph, chairman of the department of urology at the University of Rochester Medical Center and keynote at the May 2025 MPCC Symposium. In this conversation with host Jordan Rich, Dr. Joseph furthers his keynote topics, discussing the history, benefits, and future development of robotic surgery for prostate cancer. The technology,…
In this second of a two-part podcast episode detailing new treatments for prostate cancer, Dr. Phillip Davis and Dr. Dan Stevens highlight the increasing accessibility of molecular imaging and radioligy and therapy across the US and the potential for earlier use of these technologies. They also discuss the promise of future advancements including personalized cancer treatments, the use of new…
In this first of a two-part podcast episode, Dr. Phillip Davis and Dr. Dan Stevens follow up on the symposium topic of “New Treatments for Prostate Cancer.” In Part I, Dr. Philip Davis explains molecular imaging, which uses a low dose of radioactive medicine to detect cancer and other diseases early, as well as providing doctors with both anatomic and functional information on the cancer cells.…
